Intensity Therapeutics Signs Collaboration Agreement With The Swiss Group For Clinical Cancer Research SAKK To Conduct Phase 2 Breast Cancer Trial In Europe For INT230-6
Intensity Therapeutics 與瑞士臨床癌症研究集團簽署合作協議 SAKK 將在歐洲進行 INT230-6 的二期乳腺癌試驗
Intensity Therapeutics Signs Collaboration Agreement With The Swiss Group For Clinical Cancer Research SAKK To Conduct Phase 2 Breast Cancer Trial In Europe For INT230-6
Intensity Therapeutics 與瑞士臨床癌症研究集團簽署合作協議 SAKK 將在歐洲進行 INT230-6 的二期乳腺癌試驗
使用瀏覽器的分享功能,分享給你的好友吧